Perbedaan Batulicin Nusantara Maritim Tbk dan Merck Tbk.: Batulicin Nusantara Maritim Tbk diperdagangkan di Rp930 (kapitalisasi pasar 3,22 T, volume 24 jam 11,6 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.740 (kapitalisasi pasar 1,68 T, volume 24 jam 22,8 rb). Perbedaan utamanya: Batulicin Nusantara Maritim Tbk lebih besar dari sisi kapitalisasi pasar, dan Merck Tbk. lebih aktif diperdagangkan (22,8 rb vs 11,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BESS | MERK | |
|---|---|---|
Kapitalisasi Pasar | 3,22 T | 1,68 T |
Volume | 11,6 rb | 22,8 rb |
Lot | 116 | 228 |
Perputaran | 10,49 jt | 82,9 jt |
Harga Rata-rata | 904,18 | 3.636,14 |
Nilai Transaksi | 10,49 jt | 82,9 jt |
Harga Ekuilibrium Indikatif | — | 3.520 |
Volume Ekuilibrium Indikatif | — | 60 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Batulicin Nusantara Maritim Tbk (the “Company”) was established based on Notarial Deed No. 53 dated May 25, 2011 of Muhammad Faried Zain, S.H., M.H., notary in Banjarmasin. The Company’s immediate Parent Company is PT Batulicin Enam Sembilan Transportasi, and its Ultimate Parent Company is PT Batulicin Enam Sembilan. The Company started its commercial operations in 2012.
Selengkapnya di halaman BESS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →